Reducing The Use Of Empiric Antibiotic Therapy In Covid-19 On Hospital Admission

Decorative image of the AMR Learning Lounge

Reducing The Use Of Empiric Antibiotic Therapy In Covid-19 On Hospital Admission

SUMMARY

Natasha N. Pettit, PharmD, and her colleagues at the University of Chicago Medical Center tested guidelines they created for antibiotic initiation and discontinuation for CABP (community-acquired bacterial pneumonia) in COVID-19 patients. The guidelines reduced total antibiotic use for all COVID-19 patients from 74.5% to 42% without any clinical differences observed in patient outcomes.

FEATURED EXPERTS

Natasha N. Pettit, PharmD, BCPS, Pharmacy Director of Antimicrobial Stewardship at University of Chicago Medicine

GET STARTED

University of Chicago Medicine offers a compelling case study of ASP guidelines successfully lowering antibiotic usage.

Take me there now!

Estimated reading time: 11 minutes

We want to hear from you!

Your feedback helps us continue to provide resources and content specific to your needs.

Take Our Poll

US Solutions

Antimicrobial Stewardship Solutions

Antimicrobial Resistance is undermining modern medicine and putting patients at risk of premature death. bioMérieux is committed to preserving antibiotic efficacy with the right diagnostic tests that guide appropriate and responsible use of antibiotics to ensure they remain lifesaving for posterity.

Learn More

PUBLISHED BY

BMC Infectious Diseases Journal
June 2, 2021